General MedicationsTOPICAL, VAGINALGeneric
MONISTAT DUAL- PAK
MICONAZOLE NITRATE
Standard Dose
1.2GM;2%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview MONISTAT DUAL- PAK is listed in Drugs@FDA under application 020968 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient MICONAZOLE NITRATE Form and strength CREAM, SUPPOSITORY;TOPICAL, VAGINAL - 1.2GM;2% Sponsor PERSONAL PRODS Submission history Latest submission status date: 2014-02-11 00:00:00.
Structured Monograph
Clinical summary
Approval overview MONISTAT DUAL- PAK is listed in Drugs@FDA under application 020968 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MICONAZOLE NITRATE Form and strength CREAM, SUPPOSITORY;TOPICAL, VAGINAL - 1.2GM;2% Sponsor PERSONAL PRODS Submission history Latest submission status date: 2014-02-11 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.